{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:01:34Z","timestamp":1770822094967,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.humpath.2011.12.019","type":"journal-article","created":{"date-parts":[[2012,4,19]],"date-time":"2012-04-19T07:04:14Z","timestamp":1334819054000},"page":"1704-1710","source":"Crossref","is-referenced-by-count":17,"title":["Immunohistochemical analysis of polycomb group protein expression in advanced gastric cancer"],"prefix":"10.1016","volume":"43","author":[{"given":"Hyunjoo","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Och","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woon Yong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han Kyeom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aeree","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baek-hui","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2011.12.019_bb0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2217\/fon.10.157","article-title":"Epigenetic factors in cancer development: polycomb group proteins","volume":"7","author":"Piunti","year":"2011","journal-title":"Future Oncol"},{"key":"10.1016\/j.humpath.2011.12.019_bb0010","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nrc2736","article-title":"Polycomb group proteins: navigators of lineage pathways led astray in cancer","volume":"9","author":"Bracken","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2011.12.019_bb0015","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1182\/blood-2010-05-267096","article-title":"Polycomb proteins in hematologic malignancies","volume":"116","author":"Martin-Perez","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.12.019_bb0020","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer","volume":"419","author":"Varambally","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2011.12.019_bb0025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.eururo.2006.11.020","article-title":"Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features","volume":"52","author":"van Leenders","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2011.12.019_bb0030","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1523\/JNEUROSCI.0968-09.2009","article-title":"BMI1 sustains human glioblastoma multiforme stem cell renewal","volume":"29","author":"Abdouh","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.humpath.2011.12.019_bb0035","doi-asserted-by":"crossref","first-page":"9211","DOI":"10.1158\/0008-5472.CAN-09-1622","article-title":"EZH2 is essential for glioblastoma cancer stem cell maintenance","volume":"69","author":"Suva","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2011.12.019_bb0040","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1158\/1078-0432.CCR-05-1533","article-title":"Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer","volume":"12","author":"Collett","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2011.12.019_bb0045","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1158\/1078-0432.CCR-06-0788","article-title":"Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas","volume":"12","author":"Silva","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2011.12.019_bb0050","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1593\/neo.04160","article-title":"Increased expression of the EZH2 polycomb group gene in BMI-1\u2013positive neoplastic cells during bronchial carcinogenesis","volume":"6","author":"Breuer","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.humpath.2011.12.019_bb0055","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/labinvest.2008.52","article-title":"The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma","volume":"88","author":"Sasaki","year":"2008","journal-title":"Lab Invest"},{"key":"10.1016\/j.humpath.2011.12.019_bb0060","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1751-2980.2010.00420.x","article-title":"Expression of polycomb protein EZH2 in multi-stage tissues of gastric carcinogenesis","volume":"11","author":"Cai","year":"2010","journal-title":"J Dig Dis"},{"key":"10.1016\/j.humpath.2011.12.019_bb0065","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1440-1746.2009.06045.x","article-title":"Bmi-1 is critical for the proliferation and invasiveness of gastric carcinoma cells","volume":"25","author":"Li","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.humpath.2011.12.019_bb0070","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejso.2004.11.001","article-title":"Clinical significance of enhancer of zeste homolog 2 expression in colorectal cancer cases","volume":"31","author":"Mimori","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.humpath.2011.12.019_bb0075","first-page":"349","article-title":"Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas","volume":"16","author":"Weikert","year":"2005","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.humpath.2011.12.019_bb0080","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1016\/j.juro.2009.08.014","article-title":"Expression profile of the polycomb group protein enhancer of zeste homologue 2 and its prognostic relevance in renal cell carcinoma","volume":"182","author":"Hinz","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2011.12.019_bb0085","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1186\/bcr2214","article-title":"EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer","volume":"10","author":"Pietersen","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.humpath.2011.12.019_bb0090","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/sj.bjc.6605333","article-title":"Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis","volume":"101","author":"Fluge","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2011.12.019_bb0095","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/modpathol.2008.17","article-title":"Loss of BMI-1 expression is associated with clinical progress of malignant melanoma","volume":"21","author":"Bachmann","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2011.12.019_bb0100","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3727\/096504009789745502","article-title":"Knockdown of Bmi-1 impairs growth and invasiveness of human gastric carcinoma cells","volume":"17","author":"Xiao","year":"2009","journal-title":"Oncol Res"},{"key":"10.1016\/j.humpath.2011.12.019_bb0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1476-4598-9-40","article-title":"BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer","volume":"9","author":"Zhang","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1016\/j.humpath.2011.12.019_bb0110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jso.20934","article-title":"Bmi-1 expression predicts prognosis for patients with gastric carcinoma","volume":"97","author":"Liu","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.humpath.2011.12.019_bb0115","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3748\/wjg.15.2145","article-title":"Clinicopathological significance of B-cell\u2013specific Moloney murine leukemia virus insertion site 1 expression in gastric carcinoma and its precancerous lesion","volume":"15","author":"Zhao","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.humpath.2011.12.019_bb0120","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-0463.2009.02579.x","article-title":"Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and metastasis in gastric cancer","volume":"118","author":"Choi","year":"2010","journal-title":"APMIS"},{"key":"10.1016\/j.humpath.2011.12.019_bb0125","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1349-7006.2006.00203.x","article-title":"Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer","volume":"97","author":"Matsukawa","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1016\/j.humpath.2011.12.019_bb0130","series-title":"AJCC cancer staging manual","author":"Edge","year":"2010"},{"key":"10.1016\/j.humpath.2011.12.019_bb0135","series-title":"World Health Organization., International Agency for Research on Cancer. Pathology and genetics of tumours of the digestive system","author":"Aaltonen","year":"2000"},{"key":"10.1016\/j.humpath.2011.12.019_bb0140","first-page":"819","article-title":"Expression pattern and clinical significance of DNA methyltransferase 3B variants in gastric carcinoma","volume":"23","author":"Su","year":"2010","journal-title":"Oncol Rep"},{"key":"10.1016\/j.humpath.2011.12.019_bb0145","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s10620-007-0145-2","article-title":"The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer","volume":"53","author":"Ding","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.humpath.2011.12.019_bb0150","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ccr.2010.03.018","article-title":"An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression","volume":"17","author":"Yu","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2011.12.019_bb0155","article-title":"Cooperation between polycomb and androgen receptor during oncogenic transformation","author":"Zhao","year":"2011","journal-title":"Genome Res"},{"key":"10.1016\/j.humpath.2011.12.019_bb0160","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/sj.bjc.6604360","article-title":"Low BMI-1 expression is associated with an activated BMI-1\u2013driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma","volume":"98","author":"Engelsen","year":"2008","journal-title":"Br J Cancer"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817711005284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817711005284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T01:28:09Z","timestamp":1543022889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817711005284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0046817711005284"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2011.12.019","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}